Literature DB >> 22828642

Trough concentrations of vancomycin: adult therapeutic targets are not appropriate for children.

Claire L Gordon1, Chantelle Thompson, Jonathan R Carapetis, John Turnidge, Charles Kilburn, Bart J Currie.   

Abstract

Despite the need for effective vancomycin therapy, there are few data guiding vancomycin monitoring in children. We reviewed retrospectively vancomycin use in children 1 month to 12 years of age. Initial and adjusted target trough vancomycin concentrations in serum were infrequently achieved regardless of the dosing schedule. Currently recommended trough concentrations need to be re-examined with a more detailed pharmacokinetic study in children.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22828642     DOI: 10.1097/INF.0b013e31826a3eaf

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  13 in total

Review 1.  Determining the optimal vancomycin daily dose for pediatrics: a meta-analysis.

Authors:  Geisa Cristina da Silva Alves; Samuel Dutra da Silva; Virginia Paula Frade; Danielle Rodrigues; André de Oliveira Baldoni; Whocely Victor de Castro; Cristina Sanches
Journal:  Eur J Clin Pharmacol       Date:  2017-08-04       Impact factor: 2.953

2.  Balancing vancomycin efficacy and nephrotoxicity: should we be aiming for trough or AUC/MIC?

Authors:  Karisma Patel; Ashley S Crumby; Holly D Maples
Journal:  Paediatr Drugs       Date:  2015-04       Impact factor: 3.022

3.  Vancomycin monitoring in children using bayesian estimation.

Authors:  Jennifer Le; Becky Ngu; John S Bradley; William Murray; Austin Nguyen; Lyn Nguyen; Gale L Romanowski; Tiana Vo; Edmund V Capparelli
Journal:  Ther Drug Monit       Date:  2014-08       Impact factor: 3.681

4.  A whole blood microsampling assay for vancomycin: development, validation and application for pediatric clinical study.

Authors:  Ganesh S Moorthy; Kevin J Downes; Christina Vedar; Athena F Zuppa
Journal:  Bioanalysis       Date:  2020-09-18       Impact factor: 2.681

5.  The effect of age and weight on vancomycin serum trough concentrations in pediatric patients.

Authors:  Theresa Madigan; Ronald M Sieve; Kevin K Graner; Ritu Banerjee
Journal:  Pharmacotherapy       Date:  2013-07-17       Impact factor: 4.705

Review 6.  Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants.

Authors:  Jessica K Roberts; Chris Stockmann; Jonathan E Constance; Justin Stiers; Michael G Spigarelli; Robert M Ward; Catherine M T Sherwin
Journal:  Clin Pharmacokinet       Date:  2014-07       Impact factor: 6.447

7.  Population pharmacokinetics of vancomycin and AUC-guided dosing in Chinese neonates and young infants.

Authors:  Yewei Chen; Dan Wu; Min Dong; Yiqing Zhu; Jinmiao Lu; Xiaoxia Li; Chao Chen; Zhiping Li
Journal:  Eur J Clin Pharmacol       Date:  2018-03-30       Impact factor: 2.953

8.  Vancomycin dosing in healthy-weight, overweight, and obese pediatric patients.

Authors:  Lea S Eiland; Kalyani B Sonawane
Journal:  J Pediatr Pharmacol Ther       Date:  2014-07

9.  Pharmacodynamic Characteristics of Nephrotoxicity Associated With Vancomycin Use in Children.

Authors:  Jennifer Le; Pamela Ny; Edmund Capparelli; James Lane; Becky Ngu; Richard Muus; Gale Romanowski; Tiana Vo; John Bradley
Journal:  J Pediatric Infect Dis Soc       Date:  2014-11-03       Impact factor: 3.164

Review 10.  Staphylococcus aureus - antimicrobial resistance and the immunocompromised child.

Authors:  J Chase McNeil
Journal:  Infect Drug Resist       Date:  2014-05-07       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.